This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Laetrile controversy profiles cancer therapy advocate
The piece surveys amygdalin known as laetrile B 17, its status as an outlaw drug, and arguments that it may serve as analgesic or vitamin. It details promoters like the McNaughton Foundation, doctors claims of pain relief, price rises, black market activity, and legal routes allowing six month supplies for terminal cancer patients.
MENTIONED IN THIS ARTICLE
Patricia MC Cormack
UPI
Food and Drug Administration
Committee For Freedom of Choice
McNaughton Foundation
Sausalito
Calif
Doctors
Dean Burk
United Press International
Burk
National Cancer Institute
Contreras
Hans A. Nieper
Hanover
Germany
McNaughton
Arlington House
Culbert
Mexico
Monte Carlo
Spain
West Germany
Krebs Family
San Francisco
United States
Tijuana
CytoPharma
Today’s Health
American Medical Association
Rochester, Minn
Post- Bulletin
Cancer Control Society
Los Angeles
Washington, D.C
Hammond
Ind
Rochester
Minn
Sacramento
Westlake Village
America
Donna Schuster
C.D
The
Norman Saliba
Gallatin
Tenn
Memphis